Cleveland BioLabs, Zhejiang Hisun Pharmaceutical deal

Cleveland BioLabs granted Zhejiang Hisun an exclusive license to develop and commercialize Protectan CBLB612 in China for 20 years. The synthetic lipopeptide with a chemical structure derived from a ...